BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29208460)

  • 1. RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.
    D'Aloia A; Berruti G; Costa B; Schiller C; Ambrosini R; Pastori V; Martegani E; Ceriani M
    Exp Cell Res; 2018 Jan; 362(2):349-361. PubMed ID: 29208460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RalGPS2 Interacts with Akt and PDK1 Promoting Tunneling Nanotubes Formation in Bladder Cancer and Kidney Cells Microenvironment.
    D'Aloia A; Arrigoni E; Costa B; Berruti G; Martegani E; Sacco E; Ceriani M
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of RalGPS2, a murine guanine nucleotide exchange factor for RalA GTPase.
    Ceriani M; Scandiuzzi C; Amigoni L; Tisi R; Berruti G; Martegani E
    Exp Cell Res; 2007 Jul; 313(11):2293-307. PubMed ID: 17462626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PH-PxxP domain of RalGPS2 promotes PC12 cells differentiation acting as a dominant negative for RalA GTPase activation.
    Ceriani M; Amigoni L; Scandiuzzi C; Berruti G; Martegani E
    Neurosci Res; 2010 Mar; 66(3):290-8. PubMed ID: 20025911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LST1 promotes the assembly of a molecular machinery responsible for tunneling nanotube formation.
    Schiller C; Diakopoulos KN; Rohwedder I; Kremmer E; von Toerne C; Ueffing M; Weidle UH; Ohno H; Weiss EH
    J Cell Sci; 2013 Feb; 126(Pt 3):767-77. PubMed ID: 23239025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RalBP1 is necessary for metastasis of human cancer cell lines.
    Wu Z; Owens C; Chandra N; Popovic K; Conaway M; Theodorescu D
    Neoplasia; 2010 Dec; 12(12):1003-12. PubMed ID: 21170262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.
    O Santos A; Parrini MC; Camonis J
    PLoS One; 2016; 11(5):e0154840. PubMed ID: 27149377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exo84 and Sec5 are competitive regulatory Sec6/8 effectors to the RalA GTPase.
    Jin R; Junutula JR; Matern HT; Ervin KE; Scheller RH; Brunger AT
    EMBO J; 2005 Jun; 24(12):2064-74. PubMed ID: 15920473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.
    Takaya A; Ohba Y; Kurokawa K; Matsuda M
    Mol Biol Cell; 2004 Jun; 15(6):2549-57. PubMed ID: 15034142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sec5 and Exo84 mediate distinct aspects of RalA-dependent cell polarization.
    Hazelett CC; Yeaman C
    PLoS One; 2012; 7(6):e39602. PubMed ID: 22761837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis.
    Issaq SH; Lim KH; Counter CM
    Mol Cancer Res; 2010 Feb; 8(2):223-31. PubMed ID: 20145037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex.
    Fukai S; Matern HT; Jagath JR; Scheller RH; Brunger AT
    EMBO J; 2003 Jul; 22(13):3267-78. PubMed ID: 12839989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex.
    Hase K; Kimura S; Takatsu H; Ohmae M; Kawano S; Kitamura H; Ito M; Watarai H; Hazelett CC; Yeaman C; Ohno H
    Nat Cell Biol; 2009 Dec; 11(12):1427-32. PubMed ID: 19935652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
    Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
    Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The exocyst complex binds the small GTPase RalA to mediate filopodia formation.
    Sugihara K; Asano S; Tanaka K; Iwamatsu A; Okawa K; Ohta Y
    Nat Cell Biol; 2002 Jan; 4(1):73-8. PubMed ID: 11744922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and involvement of Ral GTPases in colorectal cancer.
    Martin TD; Samuel JC; Routh ED; Der CJ; Yeh JJ
    Cancer Res; 2011 Jan; 71(1):206-15. PubMed ID: 21199803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunneling nanotubes: emerging view of their molecular components and formation mechanisms.
    Kimura S; Hase K; Ohno H
    Exp Cell Res; 2012 Aug; 318(14):1699-706. PubMed ID: 22652450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.
    Oxford G; Smith SC; Hampton G; Theodorescu D
    Oncogene; 2007 Nov; 26(50):7143-52. PubMed ID: 17496927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the exocyst protein Exo84 by TBK1 promotes insulin-stimulated GLUT4 trafficking.
    Uhm M; Bazuine M; Zhao P; Chiang SH; Xiong T; Karunanithi S; Chang L; Saltiel AR
    Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
    Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
    Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.